(0.04%) 5 519.00 points
(0.13%) 39 895 points
(0.09%) 19 768 points
(-0.09%) $81.56
(0.43%) $2.82
(-0.23%) $2 338.90
(0.17%) $29.58
(0.54%) $1 007.20
(0.08%) $0.932
(-0.09%) $10.52
(0.02%) $0.788
(-0.85%) $87.25
-2.26% $ 10.83
Live Chart Being Loaded With Signals
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 525 099 |
Średni wolumen | 640 153 |
Kapitalizacja rynkowa | 633.94M |
EPS | $-1.420 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $-1.200 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.43 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0180 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-31 | Henderson Molly | Buy | 7 500 | Common Stoock |
2024-05-31 | Nabulsi Azmi | Buy | 7 500 | Common Stoock |
2024-05-29 | Karbe Frank | Buy | 25 000 | Common Stock |
2024-05-23 | Topper James N | Buy | 10 500 | Common Stock |
2024-05-23 | Topper James N | Sell | 17 500 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-48.71 |
Last 96 transactions |
Buy: 2 248 419 | Sell: 4 522 898 |
Wolumen Korelacja
Phathom Pharmaceuticals Korelacja
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Phathom Pharmaceuticals Korelacja - Waluta/Towar
Phathom Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $682 000 |
Zysk brutto: | $515 000 (75.51 %) |
EPS: | $-3.93 |
FY | 2023 |
Przychody: | $682 000 |
Zysk brutto: | $515 000 (75.51 %) |
EPS: | $-3.93 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-620 000 (0.00 %) |
EPS: | $-5.70 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.86 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Phathom Pharmaceuticals
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej